DENTSPLY SIRONA Inc
NASDAQ:XRAY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
US |
|
Jaypee Infratech Ltd
NSE:JPINFRATEC
|
IN |
|
Qnb Finansal Kiralama AS
IST:QNBFK.E
|
TR |
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc., a leading figure in the dental industry, has crafted a compelling narrative of innovation and strategic growth since its inception. The roots of this global dental solutions company can be traced back to the merger of DENTSPLY International and Sirona Dental Systems in 2016. This fusion combined strengths in dental consumables and cutting-edge equipment, creating a formidable presence in the dental market. Headquartered in Charlotte, North Carolina, with operations spanning the globe, DENTSPLY SIRONA is renowned for its comprehensive suite of dental solutions. From dental instruments and restorative materials to high-tech imaging systems and digital dental equipment, the company is at the forefront of providing holistic solutions for dental professionals. Its product line is meticulously designed to enhance clinical outcomes, improve patient experiences, and support the evolving needs of dental practices worldwide.
Central to DENTSPLY SIRONA's business model is its relentless commitment to research and development, which fuels its aggressive innovations and product enhancements. This dedication to cutting-edge technology and quality assurance underpins the company's revenue streams, primarily derived from its diverse range of product segments. These encompass consumables, dental technology, and equipment solutions, which are marketed directly to dental professionals and through distributors. By capitalizing on its expansive distribution network and strategic partnerships, DENTSPLY SIRONA maintains a robust pipeline of products, ensuring steady demand and consistent economic performance in a rapidly advancing, innovation-driven industry. Through strategic acquisitions, global expansion, and a focus on education and training for dental professionals, the company continues to solidify its market position while driving forward the evolution of dental care.
DENTSPLY SIRONA Inc., a leading figure in the dental industry, has crafted a compelling narrative of innovation and strategic growth since its inception. The roots of this global dental solutions company can be traced back to the merger of DENTSPLY International and Sirona Dental Systems in 2016. This fusion combined strengths in dental consumables and cutting-edge equipment, creating a formidable presence in the dental market. Headquartered in Charlotte, North Carolina, with operations spanning the globe, DENTSPLY SIRONA is renowned for its comprehensive suite of dental solutions. From dental instruments and restorative materials to high-tech imaging systems and digital dental equipment, the company is at the forefront of providing holistic solutions for dental professionals. Its product line is meticulously designed to enhance clinical outcomes, improve patient experiences, and support the evolving needs of dental practices worldwide.
Central to DENTSPLY SIRONA's business model is its relentless commitment to research and development, which fuels its aggressive innovations and product enhancements. This dedication to cutting-edge technology and quality assurance underpins the company's revenue streams, primarily derived from its diverse range of product segments. These encompass consumables, dental technology, and equipment solutions, which are marketed directly to dental professionals and through distributors. By capitalizing on its expansive distribution network and strategic partnerships, DENTSPLY SIRONA maintains a robust pipeline of products, ensuring steady demand and consistent economic performance in a rapidly advancing, innovation-driven industry. Through strategic acquisitions, global expansion, and a focus on education and training for dental professionals, the company continues to solidify its market position while driving forward the evolution of dental care.
Q4 Results: Revenue, EBITDA margin, and adjusted EPS were all in line with expectations from the Q3 call.
Revenue: Q4 revenue was $961 million, up 6.2% reported and 2.5% in constant currency.
Profitability: Adjusted EBITDA margin for Q4 was 14.1%, down 10 bps; full year 2025 EBITDA margin rose to 18.1%, up 150 bps.
EPS: Adjusted EPS for Q4 was $0.27, up 4.9%; full year 2025 adjusted EPS was $1.60, down 4.6%.
Dividend: The company eliminated its dividend, freeing up $128 million annually for debt reduction and share repurchases.
2026 Guidance: Sales expected between $3.5B and $3.6B (down 1% to 3% operationally); adjusted EPS expected between $1.40 and $1.50.
Restructuring: Announced a restructuring program to unlock $120 million in annual savings, with expected nonrecurring charges of $55–65 million.
R&D Investment: Double-digit increase in R&D spend planned for 2026 to accelerate innovation, especially in DS Core, EDS, and ortho.
